![]() |
![]() |
My Amedeo
![]() ![]() ![]() |
![]() |
|||||||||
Stroke prevention |
Autoimmune Disorders |
Free Subscription
1 Acta Neurol Scand |
Retrieve available abstracts of this week’s articles:
HTML format |
Single Articles |
AMEDEO Autoimmune Disorders is free of charge.
Nucleotide oligomerization domain polymorphism confers no risk to Guillain-Barre
syndrome.
Acta Neurol Scand. 2022 Jun 2. doi: 10.1111/ane.13649.
PubMed
Abstract available
Linking lesions in sensorimotor cortex to contralateral hand function in multiple
sclerosis: a 7 T MRI study.
Brain. 2022 Jun 2. pii: 6599027. doi: 10.1093.
PubMed
Abstract available
Antibody-Mediated Targeting of a Hybrid-Insulin-Peptide Towards Neonatal Thymic
Langerin+ Cells Enhances T Cell Central Tolerance and Delays Autoimmune Diabetes.
Diabetes. 2022 May 27. pii: 147050. doi: 10.2337/db21-1069.
PubMed
Abstract available
Early B cells repopulation in multiple sclerosis patients treated with rituximab
is not predictive of a risk of relapse or clinical progression.
J Neurol. 2022 Jun 2. pii: 10.1007/s00415-022-11197.
PubMed
Abstract available
Retinal inner nuclear layer thinning is decreased and associates with the
clinical outcome in ocrelizumab-treated primary progressive multiple sclerosis.
J Neurol. 2022 Jun 1. pii: 10.1007/s00415-022-11183.
PubMed
Abstract available
A role for the Epstein-Barr virus in multiple sclerosis aetiology?
J Neurol. 2022 May 31. pii: 10.1007/s00415-022-11177.
PubMed
Siponimod vs placebo in active secondary progressive multiple sclerosis: a post
hoc analysis from the phase 3 EXPAND study.
J Neurol. 2022 May 31. pii: 10.1007/s00415-022-11166.
PubMed
Abstract available
Rho GTPase-activating protein 10 (ARHGAP10/GRAF2) is a novel autoantibody target
in patients with autoimmune encephalitis.
J Neurol. 2022 May 27. pii: 10.1007/s00415-022-11178.
PubMed
Abstract available
Somatic Mutation in UBA1 and ANCA-associated Vasculitis.
J Rheumatol. 2021;48:1626-1627.
PubMed
Fear of the Unknown: Can We Help Individuals With a Systemic Autoimmune Rheumatic
Disease Deal With Uncertainty?
J Rheumatol. 2022 Jun 1. pii: jrheum.220502. doi: 10.3899/jrheum.220502.
PubMed
Abstract available
Retinal layer thinning as a biomarker of long-term disability progression in
multiple sclerosis.
Mult Scler. 2022 Jun 2:13524585221097566. doi: 10.1177/13524585221097566.
PubMed
Abstract available
CNS demyelination associated with immune dysregulation and a novel CTLA-4
variant.
Mult Scler. 2021;27:1464-1467.
PubMed
Abstract available
Ageing reduces potential for remyelination in multiple sclerosis.
Nat Rev Neurol. 2022 May 31. pii: 10.1038/s41582-022-00680.
PubMed
Ocular myasthenia gravis and risk factors for developing a secondary
generalisation: description of a Spanish series.
Neurologia (Engl Ed). 2022 May 27. pii: S2173-5808(22)00053.
PubMed
Abstract available
Evaluation of renal injury and function biomarkers, including symmetric
dimethylarginine (SDMA), in the rat passive Heymann nephritis (PHN) model.
PLoS One. 2022;17:e0269085.
PubMed
Abstract available
Experiences of persons with Multiple Sclerosis with lifestyle adjustment-A
qualitative interview study.
PLoS One. 2022;17:e0268988.
PubMed
Abstract available
"I wanna live and not think about the future" what place for advance care
planning for people living with severe multiple sclerosis and their families? A
qualitative study.
PLoS One. 2022;17:e0265861.
PubMed
Abstract available
Outcomes of Early-pregnancy Antithyroid Drug Withdrawal in Graves' Disease: A
Preliminary Prospective Follow-up Study.
Thyroid. 2022 Jun 1. doi: 10.1089/thy.2022.0088.
PubMed
Abstract available
Thank you for your interest in scientific medicine.
This policy is made possible thanks to
a media sponsorship by